Top

Published in:

Open Access 01-12-2022 | Addiction | Study protocol

Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial

Authors: Annabel S. Mueller-Stierlin, Jeanette Röhrig, Christian Goetzl, Michael Krausz, Jutta Lehle, Elke Prestin, Vanessa-Emily Schoch, Lorenz Sutter, Jean Westenberg, Maurice Cabanis

Published in: Trials | Issue 1/2022

Abstract

Background

The implementation of person-centred, need-oriented and flexible care for people with substance-related problems is often insufficient, in large part due to the complexity of addiction support services among different providers. A standardized online assessment and subsequent sector-independent treatment coordination could provide individuals with more appropriate services, thereby making better use of individual services and leading to a more effective addiction support system as a whole. The aim of this study is to determine the effectiveness and cost-effectiveness of sector-independent treatment coordination following an online assessment, in comparison with the current standard of care and treatment process in Germany.

Methods

The sample size of this randomized, controlled trial has been set to a total of 400 participants with substance-related problems. Participants living in Stuttgart, Germany, will be randomly allocated to (1) the intervention group with immediate online assessment and subsequent sector-independent treatment coordination (ASSIST) or (2) the waitlist group. Participants in the waitlist group will initially remain in usual care and only be provided with the online assessment 6 months later. Short-term effects (over 2 months) and medium-term effects (over 6 months) of ASSIST will be compared between the intervention and the waitlist groups. The primary outcome is improved treatment satisfaction. Secondary outcomes include improved subjective quality of life and empowerment, reductions in patients’ substance use, unmet needs and illness-related clinical and social impairment. Health economic evaluation as well as quantitative and qualitative process evaluations will be conducted.

Discussion

The results of this study are expected to provide information on whether sector-independent treatment coordination following an online assessment contributes to improved health care service provision for people with substance-related problems. This randomized controlled trial will help identify facilitators and barriers to the sustainable implementation of a cross-sectoral care concept in substance abuse services.

Trial registration

German Clinical Trial Register DRKS00026996. Registered on 29 October 2021

Atzendorf J, Rauschert C, Seitz N-N, Lochbühler K, Kraus L. The use of alcohol, tobacco, illegal drugs and medicines: an estimate of consumption and substance-related disorders in Germany. Dtsch Arztebl Int. 2019;116:577–84. https://doi.org/10.3238/arztebl.2019.0577.CrossRefPubMedPubMedCentral

Deutsche Hauptstelle für Suchtfragen (DHS) e.V., editor. Jahrbuch Sucht 2020. Lengerich: Pabst Science Publishers; 2020. ISBN 978-3-95853-589-3.

Matos EG, Atzendorf J, Kraus L, Piontek D. Substanzkonsum in der Allgemeinbevölkerung in Deutschland. Sucht. 2016;62:271–81. https://doi.org/10.1024/0939-5911/a000445.CrossRef

Thomasius R, Arnaud N, Holtmann M, Kiefer F. Substanzbezogene Störungen im Jugend- und jungen Erwachsenenalter. [Substance-related disorders in adolescence and young adulthood]. Z Kinder Jugendpsychiatr Psychother. 2020;48:448–52. https://doi.org/10.1024/1422-4917/a000725.CrossRefPubMed

World Health Organization. WHO/UNODC/UNAIDS position paper: substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: Switzerland; 2004.

International Narcotics Control Board. Report of the International Narcotics Control Board for 2017 (E/INCB/2017/1); 2017.

Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS One. 2019;14:e0221153. https://doi.org/10.1371/journal.pone.0221153.CrossRefPubMedPubMedCentral

Häuser W, Schug S, Furlan AD. The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents. Pain Rep. 2017;2:e599. https://doi.org/10.1097/PR9.0000000000000599.CrossRefPubMedPubMedCentral

Mann KF. Alkoholismus: Neue ärztliche Aufgaben bei Alkoholproblemen. Deutsches Ärzteblatt. 2002;99:A-632 / B–515 / C-486.

10.

Bischof G, Rumpf H-J, Meyer C, Hapke U, John U. Inanspruchnahme medizinischer Versorgung bei Rauchern und riskant Alkohol konsumierenden Personen: Ergebnisse einer repräsentativen Bevölkerungsstudie. [Medical care requested by smokers and at-risk alcohol consumers: results of a representative population survey]. Gesundheitswesen. 2004;66:114–20. https://doi.org/10.1055/s-2004-812706.CrossRefPubMed

11.

Leune J. Versorgung abhängigkeitskranker Menschen in Deutschland. In: Deutsche Hauptstelle für Suchtfragen (DHS) e.V., editor. Jahrbuch Sucht 2013. Lengerich: Pabst Science Publishers; 2013.

12.

Deutsche Hauptstelle für Suchtfragen (DHS) e.V. Die Versorgung von Menschen mit Suchtproblemen in Deutschland - Analyse der Hilfen und Angebote & Zukunftsperspektiven. Update. 2019; 2019. https://www.dhs.de/fileadmin/user_upload/pdf/suchthilfe/Versorgungssystem/Die_Versorgung_Suchtkranker_in_Deutschland_Update_2019.pdf. Accessed 10 Feb 2022.

13.

Wienberg G. Versorgungsstrukturen von Menschen mit Alkoholproblemen in Deutschland- eine Analyse aus Public Health Perspektive. In: Mann KF, editor. Neue Therapieansätze bei Alkoholproblemen. Lengerich: Pabst Science Publishers; 2002. p. 17–45.

14.

Sobell MB, Sobell LC. It is time for low-risk drinking goals to come out of the closet: addiction. Addiction. 2011;106:1715–7. https://doi.org/10.1111/j.1360-0443.2011.03509.x.CrossRefPubMed

15.

Gastfriend DR, Mee-Lee D. Patient placement criteria. In: Galanter M, Kleber HD, editors. Psychotherapy for the treatment of substance abuse. 1st ed. Washington, DC: American Psychiatric Association Publishing; 2010.

16.

Prestin E. (Selbst-)Ermächtigung in der Psychiatrie: Überlegungen zu Grundlagen, Möglichkeiten und Grenzen. Kerbe - Forum für soziale Psychiatrie. 2020;4:4–7.

17.

Manthey J, Kilian C, Schomerus G, Kraus L, Rehm J, Schulte B. Alkoholkonsum in Deutschland und Europa während der SARS-CoV-2 Pandemie. Sucht. 2020;66:247–58. https://doi.org/10.1024/0939-5911/a000686.CrossRef

18.

Kazemi DM, Borsari B, Levine MJ, Li S, Lamberson KA, Matta LA. A systematic review of the mHealth interventions to prevent alcohol and substance abuse. J Health Commun. 2017;22:413–32. https://doi.org/10.1080/10810730.2017.1303556.CrossRefPubMedPubMedCentral

19.

Schippers GM, Broekman TG, Buchholz A, Rutten R. Introducing a new assessment instrument: the Measurements in the Addictions for Triage and Evalution (MATE). Sucht. 2009;55:209–18. https://doi.org/10.1024/2009.04.03.CrossRef

20.

Ludwig D. Jahresbericht der Drogenbeauftragten 2020. Berlin. https://www.bundesregierung.de/bregde/service/publikationen/jahresbericht-der-drogenbeauftragten-2020-1821236.

21.

Körkel J, Nanz M. Das Paradigma Zieloffener Suchtarbeit. In: akzept e.V. Bundesverband, Deutsche AIDS-Hilfe, JES Bundesverband, editor. 3. Alternativer Drogen- und Suchtbericht; 2016. p. 196–204.

22.

Schippers GM, Broekman TG, Buchholz A, Koeter MWJ, van den Brink W. Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. Addiction. 2010;105:862–71. https://doi.org/10.1111/j.1360-0443.2009.02889.x.CrossRefPubMed

23.

Buchholz A, Rist F, Küfner H, Kraus L. Die deutsche Version des Measurements in the Addictions for Triage and Evaluation (MATE): Reliabilität. Validität und Anwendbarkeit. Sucht. 2009;55:219–42. https://doi.org/10.1024/2009.04.04.CrossRef

24.

Friedrichs A, Kraus L, Berner M, Schippers GM, Broekman TG, Rist F, et al. Adaption einer niederländischen Zuweisungsleitlinie für Patienten nach qualifiziertem Alkoholentzug – Ergebnisse einer Delphi-Befragung. Suchttherapie. 2013;14:148–54. https://doi.org/10.1055/s-0033-1354394.CrossRef

25.

Buchholz A, Dams J, Rosahl A, Hempleman J, König H-H, Konnopka A, et al. Patient-centered placement matching of alcohol-dependent patients based on a standardized intake assessment: primary outcomes of an exploratory randomized controlled trial. Eur Addict Res. 2020;26:109–21. https://doi.org/10.1159/000505913.CrossRefPubMed

26.

Buchholz A, Friedrichs A, Berner M, König H-H, Konnopka A, Kraus L, et al. Placement matching of alcohol-dependent patients based on a standardized intake assessment: rationale and design of a randomized controlled trial. BMC Psychiatry. 2014;14:286. https://doi.org/10.1186/s12888-014-0286-8.CrossRefPubMedPubMedCentral

27.

McLellan AT, Hunkeler E. Patient satisfaction and outcomes in alcohol and drug abuse treatment. Psychiatr Serv. 1998;49:573–5. https://doi.org/10.1176/ps.49.5.573.CrossRefPubMed

28.

Schreiner-Hecheltjen J. Qualitätsmanagement und Qualitätssicherung in der Medizin: Aus der Praxis für die Praxis. Berlin: Lit-Verlag; 2015.

29.

Attkisson CC, Zwick R. The client satisfaction questionnaire. Evaluation and program planning. 1982;5:233–7. https://doi.org/10.1016/0149-7189(82)90074-X.CrossRefPubMed

30.

Schmidt J, Lamprecht F, Wittmann WW. Zufriedenheit mit der stationären Versorgung.: Entwicklung eines Fragebogens und erste Validitätsuntersuchungen. [Satisfaction with inpatient management. Development of a questionnaire and initial validity studies]. Psychother Psychosom Med Psychol. 1989;39:248–55.PubMed

31.

Kilian R, Becker T, Gabriele S, Welschehold M, Hertle C, Matschinger H, et al. Die Entwicklung eines standardisierten Verfahrens zur Messung von Empowerment im Prozess der psychiatrischen Behandlung von Patienten mit schweren psychischen Erkrankungen: Abschlussbericht. Ulm: University of Ulm; 2012.

32.

Brooks RG, Rabin R, de Charro F. The measurement and valuation of health status using EQ-5D: a European perspective: evidence from the EuroQol BIOMED Research Programme. Dordrchet: Kluwer Academic Pub; 2003.

33.

Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: Handbuch für die deutschsprachigen Versionen der WHO-Instrumente zur internationalen Erfassung von Lebensqualität. Göttingen: Hogrefe; 2000.

34.

Kilian R, Bernert S, Matschinger H, Mory C, Roick C, Angermeyer MC. Die standardisierte Erfassung des Behandlungs- und Unterstützungsbedarfs bei schweren psychischen Erkrankungen - Entwicklung und Erprobung der deutschsprachigen Version des Camberwell Assessment of Need-EU. [The standardized assessment of the need for treatment and support in severe mental illness: the development and testing of the German version of the Camberwell assessment of Need-EU]. Psychiatr Prax. 2001;28(Suppl 2):S79–83. https://doi.org/10.1055/s-2001-17789.CrossRefPubMed

35.

Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815–23. https://doi.org/10.2471/BLT.09.067231.CrossRefPubMedPubMedCentral

36.

Andrews G, Kemp A, Sunderland M, von Korff M, Ustun TB. Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS One. 2009;4:e8343. https://doi.org/10.1371/journal.pone.0008343.CrossRefPubMedPubMedCentral

37.

Wing JK, Lelliott P, Beevor AS. Progress on HoNOS. Br J Psychiatry. 2000;176:392–3. https://doi.org/10.1192/bjp.176.4.392.CrossRef

38.

Andreas S, Harfst T, Dirmaier J, Kawski S, Koch U, Schulz H. A Psychometric evaluation of the German version of the ‘Health of the Nation Outcome Scales, HoNOS-D’: on the feasibility and reliability of clinician-performed measurements of severity in patients with mental disorders. Psychopathology. 2007;40:116–25. https://doi.org/10.1159/000098492.CrossRefPubMed

39.

Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–14. https://doi.org/10.1046/j.1360-0443.1995.9056072.x.CrossRefPubMed

40.

Sobell LC, Sobell MB. Timeline Follow-Back. In: Litten RZ, Allen JP, editors. Measuring alcohol consumption: psychosocial and biochemical methods. Totowa, NJ: Humana Press; 1992. p. 41–72. https://doi.org/10.1007/978-1-4612-0357-5_3.CrossRef

41.

Robinson SM, Sobell LC, Sobell MB, Leo GI. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2014;28:154–62. https://doi.org/10.1037/a0030992.CrossRefPubMed

42.

Nakovics H, Diehl A, Geiselhart H, Mann KF. Entwicklung und Validierung eines Instrumentes zur substanzunabhängigen Erfassung von Craving: Die Mannheimer Craving Scale (MaCS). [Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)]. Psychiatr Prax. 2009;36:72–8. https://doi.org/10.1055/s-2008-1067546.CrossRefPubMed

43.

Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brähler E, et al. The Somatic Symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. 2014;174:399–407. https://doi.org/10.1001/jamainternmed.2013.12179.CrossRefPubMed

44.

Gierk B, Kohlmann S, Toussaint A, Wahl I, Brünahl CA, Murray AM, et al. Assessing somatic symptom burden: a psychometric comparison of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8). J Psychosom Res. 2015;78:352–5. https://doi.org/10.1016/j.jpsychores.2014.11.006.CrossRefPubMed

45.

Kroenke K, Spitzer RL, Williams JBW, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50:613–21. https://doi.org/10.1176/appi.psy.50.6.613.CrossRefPubMed

46.

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

47.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.CrossRef

48.

Klein EM, Brähler E, Dreier M, Reinecke L, Müller KW, Schmutzer G, et al. The German version of the Perceived Stress Scale - psychometric characteristics in a representative German community sample. BMC Psychiatry. 2016;16:159. https://doi.org/10.1186/s12888-016-0875-9.CrossRefPubMedPubMedCentral

49.

Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC. Die deutsche Version des Client Sociodemographic and Service Receipt Inventory – Ein Instrument zur Erfassung psychiatrischer Versorgungskosten. [German adaptation of the client sociodemographic and service receipt inventory - an instrument for the cost of mental health care]. Psychiatr Prax. 2001;28(Suppl 2):S84–90. https://doi.org/10.1055/s-2001-17790.CrossRefPubMed

50.

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hoboken: Taylor and Francis; 1988.

51.

Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39:175–91.CrossRef

52.

Rohlmann F, Muche R, Goldschmidt L. Randomisierung in klinischen Studien. Praktische Umsetzung mit dem Randomisationsprogramm ROM. In: Schweizer B, Großmann C, Meule M, Gaus W, editors; Ulm. Ulm: Universitätsverlag Ulm; 2004. p. 168–171.

53.

van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219–42. https://doi.org/10.1177/0962280206074463.CrossRefPubMed

54.

Rubin DB. Multiple imputation for nonresponse in surveys. 99th ed. Hoboken: John Wiley & Sons Inc; 2009.

55.

Oliva H, Martin M, Görgen W, Schu M. Evaluation der ambulanten Suchthilfe und Suchtprävention der Landeshauptstadt Stuttgart: Abschlussbericht. Köln: FOGS (Gesellschaft für Forschung und Beratung im Gesundheits- und Sozialbereich); 2019. p. 181.

Title: Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial
Authors: Annabel S. Mueller-Stierlin
Jeanette Röhrig
Christian Goetzl
Michael Krausz
Jutta Lehle
Elke Prestin
Vanessa-Emily Schoch
Lorenz Sutter
Jean Westenberg
Maurice Cabanis
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Addiction
Addiction
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06343-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial

Abstract

Background

Methods

Discussion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials

PATHWEIGH, pragmatic weight management in adult patients in primary care in Colorado, USA: study protocol for a stepped wedge cluster randomized trial

Efficacy of a culturally tailored cognitive-behavioural intervention for Ethiopian children with haematological malignancies: study protocol for randomised controlled trial

Application of Pender’s health promotion model for type 2 diabetes treatment adherence: protocol for a mixed methods study in southern Iran

The effect of postoperative early lumbar drainage on delayed fever after cerebellopontine angle tumour surgery: study protocol for a randomized controlled trial

Intensity matters: protocol for a randomized controlled trial exercise intervention for individuals with chronic stroke